Rising to the Challenge: Healthy Aging Forum 2022
January 11, 2022

Rising to the Challenge: Healthy Aging Forum 2022

Date and time

January 11, 2022 ~ January 11, 2022

8am - 11:30am PST | 7pm - 10:30pm PST

11am - 2:30pm EST | 10pm - 1:30am EST

Dear Colleagues & Friends,


We are honored to have been able to unite thousands of colleagues this year from around the world for the inaugural WuXi – A*STAR Healthy Aging Forum on January 11th alongside the 2022 WuXi Global Forum. Together, we were able to inspire innovative thinking and tangible solutions for a future where everyone can enjoy a longer and healthier life.


This complimentary event brought together nearly 30 leading voices at the forefront of tackling aging challenges, convened top executives from the life science industries, preeminent researchers, and key stakeholders to promote partnerships and actionable approaches in the new era of healthy aging, uniting thousands of colleagues around the world. To our esteemed guest speakers, THANK YOU!


Special thanks to our supportive partners: BioCentury, Biocom California, Clarivate, California Life Sciences, Endpoints News, Fierce Biotech, GEN, MBC BioLabs, Medicon Valley Alliance, QB3, and Swiss Biotech Association, UK BioIndustry Association.


Please scroll down for the final agenda, or click the links below to watch this Forum on-demand (All day events or individual sessions).


Healthy Aging Forum 2022

– Conference Welcome and Opening Remarks

– Aging: The Grand Challenge

– Spotlight on Alzheimer’s Disease

– State of Aging Research

– Healthy Aging: Singapore’s Perspectives

– Prevention. Prediction. Personalization.

– The Next Frontiers in Tackling Age-Related Disorders

– How Will Technologies Shape the New Era of Healthy Aging


Thank you again, and make sure to follow us on Twitter and LinkedIn to stay up-to-date on upcoming WuXi AppTec news and events.

Agenda
  • 08:00 AM - 08:05 AM Welcome

    Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec

  • 08:05 AM - 08:20 AM Opening Remarks

    Steve Yang, Co-CEO, WuXi AppTec

    Frederick Chew, CEO, A*STAR; Chief, Public Sector Science & Technology Policy & Plans Office, Prime Minister’s Office of Singapore

    George Vradenburg, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s

  • 08:20 AM - 08:55 AM Aging: The Grand Challenge

    Kate Bingham, Managing Partner, SV Health Investors

    Luigi Ferrucci, Scientific Director, National Institute on Aging of NIH

    Paul Irving, Chairman, Milken Institute Center for the Future of Aging; Distinguished Scholar-in-Residence, USC Davis School of Gerontology

    Session Leader: Michal Preminger, Regional Head, Johnson & Johnson Innovation East North America

  • 08:55 AM - 09:30 AM Spotlight on Alzheimer’s Disease

    Niranjan Bose, Managing Director, Health & Life Sciences, Gates Ventures

    Ivan Cheung, Chairman, Eisai Inc; Global President of Neurology Business Group, Eisai Co Ltd

    George Vradenburg, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s

    Session Leader: Stacie Weninger, President of F-Prime Biomedical Research Initiative (FBRI)

  • 09:30 AM - 09:55 AM State of Aging Research

    Linda Partridge, Founding Director, Max Planck Institute for Biology of Ageing; Professor, Institute of Healthy Ageing, and GEE, UCL

    Eric Verdin, CEO & President, Buck Institute for Research on Aging

    Session Leader: Sebastien Thuault, Chief Editor, Nature Aging

  • 09:55 AM - 10:40 AM Healthy Aging: Singapore’s Perspectives

    Yap-Seng Chong, Dean, NUS Yong Loo Lin School of Medicine; Chief Clinical Officer, A*STAR

    Daniel Fung, CEO, Institute of Mental Health in Singapore

    Chien-Earn Lee, Deputy Group CEO (Regional Health System), SingHealth

    Andrea Maier, Co-Director, Centre for Healthy Longevity, National University Health System, Singapore

    Session Leader: Brian Kennedy, Distinguished Professor in Biochemistry and Physiology, the Yong Loo Lin School of Medicine, National University of Singapore

  • 10:40 AM - 11:00 AM Prevention. Prediction. Personalization.

    A conversation between Scott Berkowitz, VP & Chief Population Health Officer, Johns Hopkins Medicine; Associate Professor of Cardiology, Johns Hopkins University and Henry Brodaty, Professor of Ageing and Mental Health; Co-Director, CHeBA (Centre for Healthy Brain Ageing), UNSW Sydney

  • 11:00 AM - 11:45 AM The Next Frontiers in Tackling Age-Related Disorders

    Rita Balice-Gordon, CEO, Muna Therapeutics

    Marco Boorsma, General Partner at Forbion

    Jens Eckstein, Managing Partner, Apollo Health Ventures

    Kristen Fortney, Co-Founder and CEO, BioAge

    James Peyer, Founder & CEO, Cambrian Biopharma

    Session Leader: Dave Madge, VP of Discovery Services, WuXi AppTec

  • 11:45 AM - 12:00 PM How Will Technologies Shape the New Era of Healthy Aging

    Joseph Coughlin, Founder and Director, MIT AgeLab

Speakers
  • Hui Cai
    Hui Cai
    VP AND HEAD OF CONTENT, WUXI APPTEC
  • Steve Yang
    Steve Yang
    CO-CEO, WUXI APPTEC
  • Frederick Chew
    Frederick Chew
    CEO, A*STAR; CHIEF, PUBLIC SECTOR SCIENCE & TECHNOLOGY POLICY & PLANS OFFICE, PRIME MINISTER’S OFFICE
  •  George Vradenburg
    George Vradenburg
    CHAIRMAN, THE GLOBAL CEO INITIATIVE ON ALZHEIMER’S DISEASE; FOUNDING CHAIRMAN, DAVOS ALZHEIMER’S COLLABORATIVE; CHAIRMAN & CO-FOUNDER, USAGAINSTALZHEIMER’S
  • Kate Bingham
    Kate Bingham
    MANAGING PARTNER, SV HEALTH INVESTORS
  • Luigi Ferrucci
    Luigi Ferrucci
    SCIENTIFIC DIRECTOR, NATIONAL INSTITUTE ON AGING
  • Paul Irving
    Paul Irving
    CHAIRMAN, MILKEN INSTITUTE CENTER FOR THE FUTURE OF AGING; DISTINGUISHED SCHOLAR-IN-RESIDENCE, USC DAVIS SCHOOL OF GERONTOLOGY
  • Michal Preminger
    Michal Preminger
    REGIONAL HEAD, JOHNSON & JOHNSON INNOVATION EAST NORTH AMERICA
  • Niranjan Bose
    Niranjan Bose
    MANAGING DIRECTOR, HEALTH & LIFE SCIENCES, GATES VENTURES
  • Ivan Cheung
    Ivan Cheung
    CHAIRMAN, EISAI INC; GLOBAL PRESIDENT OF NEUROLOGY BUSINESS GROUP, EISAI CO LTD
  • Stacie Weninger
    Stacie Weninger
    PRESIDENT, FBRI
  • Linda Partridge
    Linda Partridge
    FOUNDING DIRECTOR, MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING; PROFESSOR, INSTITUTE OF HEALTHY AGEING, AND GEE, UCL
  • Eric Verdin
    Eric Verdin
    CEO & PRESIDENT, BUCK INSTITUTE FOR RESEARCH ON AGING
  • Sebastien Thuault
    Sebastien Thuault
    CHIEF EDITOR, NATURE AGING
  • Yap-Seng Chong
    Yap-Seng Chong
    DEAN, NUS YONG LOO LIN SCHOOL OF MEDICINE; CHIEF CLINICAL OFFICER, SINGAPORE INSTITUTE FOR CLINICAL SCIENCES, A*STAR
  • Daniel Fung
    Daniel Fung
    CEO, INSTITUTE OF MENTAL HEALTH IN SINGAPORE
  • Andrea Maier
    Andrea Maier
    CO-DIRECTOR, CENTRE FOR HEALTHY LONGEVITY, NATIONAL UNIVERSITY OF SINGAPORE
  • Chien-Earn Lee
    Chien-Earn Lee
    DEPUTY GROUP CEO (REGIONAL HEALTH SYSTEM), SINGHEALTH
  • Brian Kennedy
    Brian Kennedy
    PROFESSOR, DEPARTMENT OF BIOCHEMISTRY AND PHYSIOLOGY, YONG LOO LIN SCHOOL OF MEDICINE, NUS, SINGAPORE
  • Scott Berkowitz
    Scott Berkowitz
    VICE PRESIDENT & CHIEF POPULATION HEALTH OFFICER, JOHNS HOPKINS MEDICINE; ASSOCIATE PROFESSOR OF CARDIOLOGY, JOHNS HOPKINS UNIVERSITY
  • Henry Brodaty
    Henry Brodaty
    PROFESSOR OF AGEING AND MENTAL HEALTH, CO-DIRECTOR, CHEBA (CENTRE FOR HEALTHY BRAIN AGEING), UNSW SYDNEY
  • Rita Balice-Gordon
    Rita Balice-Gordon
    CEO, MUNA THERAPEUTICS
  • Marco Boorsma
    Marco Boorsma
    GENERAL PARTNER AT FORBION
  • Jens Eckstein
    Jens Eckstein
    MANAGING PARTNER, APOLLO HEALTH VENTURES
  • Kristen Fortney
    Kristen Fortney
    CO-FOUNDER AND CEO, BIOAGE
  • James Peyer
    James Peyer
    FOUNDER & CEO, CAMBRIAN BIOPHARMA
  • Dave Madge
    Dave Madge
    VP OF DISCOVERY SERVICES, WUXI APPTEC
  • Joseph Coughlin
    Joseph Coughlin
    FOUNDER AND DIRECTOR, MIT AGELAB

EVENTS

wuxi-executive-breakfast-in-basel-the-most-important-innovation-in-drug-r-d-may-be-how-the-industry-works-together
WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together
Reflections from the WuXi Executive Breakfast at Swiss Biotech Day
May 11, 2026
READ MORE

FEATURED

© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy